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Subclinical hypothyroidism (SCH), defined as elevated thyroid stimulating hormone (TSH)
and normal thyroid hormone levels, and cognitive impairment are both common in older
people. While the relation between overt hypothyroidism and cognitive impairment is
well established, data on the association between SCH and cognitive impairment are
conflicting. This systematic review and meta-analysis was performed to assess available
evidence on the association of SCH with cognition in community dwelling, relatively
healthy older adults. PubMed, EMBASE, Web of Science, COCHRANE, CINAHL,
PsycINFO, and Academic Search Premier (January 1966 to April 1, 2015) were searched
without language restrictions, as were references of key articles, for studies on the
association between SCH and cognition in older adults (>60 years). These studies were
reviewed by two independent reviewers according to predefined criteria for eligibility and
methodological quality, and data were extracted using standardized forms. Of the 844
reports initially identified, 270 remained after exclusion of duplicates. Of the 270, 15
studies comprising 19,944 subjects, of whom 1,199 had subclinical hypothyroidismwere
included. Data from the 15 studies was pooled, and meta-analyzed cross-sectionally
for global cognition [assessed by Mini-Mental State Examination (MMSE)], executive
function, and memory, using random effects models. Pooled effect size (ES) for
MMSE was −0.01 (95% CI −0.09, 0.08), with heterogeneity (I2) of 55.1%. Pooled
ES was <0.001 (95% CI −0.10, 0.09) for executive function (I2 = 13.5%), and 0.01
(95% CI −0.12, 0.14) for memory (I2 = 46.9%). In addition, prospective analysis
including four studies showed pooled ES of 0.033 (95% CI −0.001− 0.067) for MMSE
(I2 < 0.001%), indicating that subclinical hypothyroidism was not significantly associated
with accelerated cognitive decline. This systematic review and meta-analysis provides
no evidence that supports an association between SCH and cognitive impairment in
relatively healthy older adults.
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Introduction
Overt adult onset hypothyroidism, which is marked by elevated
thyroid stimulating hormone (TSH) levels and reduced levels
of circulating thyroid hormones, has been associated with
increased risk of deﬁcits in speciﬁc cognitive domains including
attention, concentration, memory, perceptual function, language,
executive function, and psychomotor speed (Constant et al.,
2005; Davis and Tremont, 2007; Samuels, 2008; Correia et al.,
2009). However, controversies persist as to whether subclinical
hypothyroidism (SCH), deﬁned as mild elevation of TSH in
the presence of normal free thyroxine (fT4), is associated with
declines in these speciﬁc cognitive domains. This is especially
relevant in the older adults, as the prevalence of subclinical
hypothyroidism increases with age and is estimated to be up to
22% in women aged more than 60 years and somewhat lower in
men (Sawin et al., 1985; Canaris et al., 2000).
Many studies have investigated whether subclinical
hypothyroidism is associated with increased risk of cognitive
impairment (Manciet et al., 1995; Cook et al., 2002; Gussekloo
et al., 2004; Roberts et al., 2006; Cardenas-Ibarra et al., 2008;
Hogervorst et al., 2008; Ceresini et al., 2009; John et al., 2009;
Park et al., 2010; de Jongh et al., 2011; Resta et al., 2012;
Yamamoto et al., 2012; Wijsman et al., 2013; Formiga et al.,
2014; Parsaik et al., 2014). However, the data are conﬂicting,
and epidemiological studies that investigated this relationship
have reported inconsistent ﬁndings. Furthermore, due to use
of diﬀerent TSH cut-oﬀ values, methodological diﬀerences,
application of varying cognitive tests for diﬀerent cognitive
domains, and diverse reporting of results by these studies, the
interpretability and comparability of their ﬁndings are hindered.
Here, we performed a systematic review of available evidence
from both cross-sectional and prospective studies on the
association between subclinical hypothyroidism and cognition in
the older adults. Furthermore, we performed a meta-analysis to
quantify the magnitude of the associations between subclinical
hypothyroidism and both global cognition as well as two speciﬁc
cognitive domains, namely executive function and memory.
Methods
Data Sources and Search Strategy
A systematic literature search was conducted of articles published
from January 1966 to April 1, 2015 on the association
between subclinical hypothyroidism and cognition in the elderly.
PubMed, EMBASE, Web of Science, COCHRANE, CINAHL,
PsycINFO, and Academic Search Premier were searched
(Datasheet 1). The design of the electronic search strategy was
done in consultation with an expert information specialist. A
thorough search was conducted on the bibliographies of key
articles in the ﬁeld and these were included in this review. To
avoid missing any relevant study in the search, broadly deﬁned
terms were used (Datasheet 1). Reference lists of key articles were
also searched for relevant articles that could have been missed.
Study Selection
Two independent reviewers (AAA and SWJ) screened the
extracted citations for eligibility. To maximize the quality and
comparability of the studies, general inclusion and exclusion
criteria were deﬁned a priori (Table 1). The titles, abstracts and
later the full-texts of the search results were screened—the studies
included were those that assessed the cognitive status of relatively
healthy (community dwelling, and considered healthy by the
authors of the original articles) elderly (aged 60 years and above)
participants with subclinical hypothyroidism.
Subclinical hypothyroidism is deﬁned as elevated TSH and
normal fT4 (Helfand, 2004). However, controversies exist
as to the upper limit of the TSH reference range. Several
reviews suggest a TSH upper limit of 4.5–5.0mIU/L (Helfand,
2004; Surks et al., 2004), but some authors suggest that
the upper limit of the TSH range should be reduced to
2.5–3.0mIU/L, based on a higher risk of progression to
overt hypothyroidism and a higher prevalence of anti-thyroid
antibodies than in euthyroid participants (Vanderpump et al.,
1995). In the absence of a consensus, the use of a speciﬁc TSH
upper limit was not pre-speciﬁed in this systematic review to
deﬁne subclinical hypothyroidism. Furthermore, fT4-values were
considered normal if indicated as normal by the authors, even if
data on fT4 were not presented.
Studies done on participants with depression [according
to the Diagnostic and Statistical Manual of Mental Disorders
(DSM) criteria], dementia, psychiatric symptoms, neurological
disorders e.g. Parkinson’s disease, and other chronic systemic
illnesses were excluded. Furthermore, participants using thyroid
medications were excluded. Three relatively large studies that
measured health status of participants with an elevated TSHwere
initially included. However, they were later excluded because
assessment of mood, and general and mental health status was
done qualitatively, without specifying whether global cognition
or speciﬁc cognitive domains were measured (Razvi et al., 2005;
Gulseren et al., 2006; Vigario et al., 2009).
Data Extraction and Quality Assessment
From each study that met the eligibility criteria, information
was extracted about study design (prospective or cross-sectional),
participant characteristics, criteria used to deﬁne subclinical
hypothyroidism, cognitive tests applied and domains tested, and
study results (eﬀect estimates, variables included for adjustments,
or matching procedures) using a standardized data-collection
form.
The two reviewers (AAA and SWJ) independently assessed the
methodological quality of included studies using a pre-deﬁned
list of criteria (Egger et al., 1997; Stroup et al., 2000) (Datasheet
2). In total, 11 key indicators were used to systematically assess
study quality. These were (1) clarity of hypothesis, (2) population
studied (convenience sample vs. population-based, deﬁned as a
random sample of the general population), (3) clear deﬁnition
of subclinical hypothyroidism (indication of TSH cut-oﬀ and
fT4-values that were used in the study), (4) detailed description
of study materials and methods, (5) validity of measurements
and cognitive tests, (6) number of cognitive domains tested
(global cognition, executive function, and/or memory), (7) clear
description of statistical methods, (8) adjustments/correction
for potential confounders, (9) clear presentation of results,
(10) generalizability to other populations, and (11) method of
outcome adjudication [use of formal adjudication procedures,
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TABLE 1 | Selection criteria for eligibility for inclusion or exclusion.
Inclusion criteria Exclusion criteria
Human studies Animal studies
Median/mean age 60 or above Younger than 60
Subclinical hypothyroidism (SCH) defined as:
- Elevated TSH and normal fT4;
- All self-defined subclinical hypothyroidism
• Elevated serum TSH in association with normal total or free T4- and
T3-values
• High-normal TSH and abnormal response to TRH
• Elevated serum TSH with normal thyroid hormone levels, without
symptoms that could be explained by overt hypothyroidism
SCH not defined
Relatively healthy elderly participants
Healthy as determined by the authors of the original articles
Full blown depression, psychiatric symptoms,
neurological disorders as Parkinson’s disease or
predefined dementia, substance abuse
Free living/community dwelling Hospitalized patients
Original research articles
including prospective studies, randomized-controlled trials, etc. that provide
baseline data
Systematic reviews, meta-analyses, reviews, conference
abstracts, web pages
Cognitive measure and domain specified Cognitive domain not well defined, e.g. “mood,” “quality
of life,” “mental health” etc.
All languages
Duplicates
deﬁned as having clear criteria for the outcome (cognitive
impairment)]. A score of “0” (lacking), “1”(incomplete), or “2”
(complete) was assigned to each of the key indicators per study,
with a maximum total score of 22.
Data Synthesis and Statistical Analysis
Authors were contacted when necessary to request more detailed
data on the association between subclinical hypothyroidism and
cognition in older adults (Gussekloo et al., 2004; de Jongh et al.,
2011; Formiga et al., 2014). The most adjusted estimates and
SD/SE were used for analysis, where available. In instances where
participants were divided into groups based on TSH-values
(tertiles/quartiles), the mean TSH-value for the whole group was
used.
Data was qualitatively synthesized and assessed for the
number of participants that were included, the deﬁnition of
subclinical hypothyroidism applied, the cognitive tests that were
used and the cognitive domains that were measured. Meta-
analysis was done by comparing estimates from participants
with subclinical hypothyroidism with those from euthyroid
participants, using data from both cross-sectional studies and
baseline data from prospective studies for the cross-sectional
analysis. Thus, only studies that provided these estimates were
included in the meta-analysis. Using Hedges method (Hedges
and Vevea, 1998), pooled estimates with standard error were
calculated ﬁrst from cross-sectional analysis of available studies,
and then for the prospective data, using the same approach.
To make eﬀect estimates comparable between studies, eﬀect
sizes (ES) were calculated from calculated means with standard
deviation of participants with subclinical hypothyroidism
compared to euthyroid participants. For studies that used >1
cognitive test (Cook et al., 2002; Gussekloo et al., 2004; John et al.,
2009; Park et al., 2010; Wijsman et al., 2013; Parsaik et al., 2014),
a pooled ES was calculated for each study. After calculating an ES
for each study, a meta-analysis was performed using a random
eﬀects model. The random eﬀects model was applied, because
it takes into account the heterogeneity between the studies. All
statistical analyses were performed using STATA version 10.
Cochrane Q-test and I2 index with a conservative p-value of 0.10
were used to evaluate the heterogeneity across individual studies.
I2-values of <25% were considered reﬂective of low, between 25
and 50% of moderate and >50% of high heterogeneity between
studies.
Results
Study Selection
Of the 844 reports initially identiﬁed, 270 remained after
exclusion of duplicates. Of the 270 reports, 210 were excluded
that were unrelated to the association between subclinical
hypothyroidism and cognition in the elderly (Figure 1), leaving
60 articles for full text analysis. Two more articles were selected
from reference lists of relevant articles. Of the 62 articles that
were selected for detailed (full text) evaluation, full texts were not
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FIGURE 1 | Flowchart showing the literature search for the systematic review.
available for six studies. Additionally, 10 studies were excluded
because the participants were not considered healthy, another
13 because the deﬁnition of subclinical hypothyroidism (high
TSH and normal fT4) was not met and four because data
was not available for systematic review [three were randomized
controlled trials (RCTs) without baseline data, and one study
reported qualitative results]. Furthermore, eight studies that
did not measure cognition as endpoint were excluded—these
either measured mental health by means of questionnaires, or
studied depression. Six other studies were excluded because the
mean/median age of the participants was less than 60 years
(Figure 1).
Two studies each were reported in Spanish and Dutch,
respectively, one in Italian and another in Czech. The researchers
(AAA and SWJ) themselves translated the two Dutch articles
into English. Another article was translated from Czech to
English by the author himself (Jensovsky et al., 2000). The
other foreign language articles were translated to English by the
researchers’ colleagues that spoke the language. These articles
were all later excluded after full-text analysis. When similar
data were published more than once (Gussekloo et al., 2004,
2006; Wiersinga, 2006), the article with the most deﬁnitive and
extractable data was included (Gussekloo et al., 2004). One study
was later dropped because it studied the eﬀect of subclinical
hypothyroidism on demented and non-demented elderly using
only clinical dementia rating, thus was incomparable with the
other selected studies in terms of results (Ganguli et al., 1996).
Fifteen observational studies met the eligibility criteria.
Study Characteristics
Table 2 shows the characteristics of the nine cross-sectional and
six prospective studies that were included in the review. In
total, the 15 studies comprised 19,944 participants, of whom
1,199 had subclinical hypothyroidism. The upper reference limit
of TSH (TSH cut-oﬀ) to deﬁne subclinical hypothyroidism
ranged from 3.6 to 10mIU/L. A total of 13 out of the 15
studies also reported fT4 measurement. The studies used varying
cognitive tests to measure a wide range of cognitive domains. The
cognitive domains that were covered included global cognition,
executive function, memory, general intelligence, attention, and
concentration, visio-spatial organization, language, and cognitive
or psychomotor speed. These cognitive domains were merged
into three main domains, namely global cognition, executive
function, and memory, as shown in Table 3. The cognitive tests
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TABLE 3 | Cognitive tests and domains used for meta-analysis.
Cognitive domain Measures and cognitive tests
Global cognition MEAMS, MMSE, MMMSE, 3MSE
Memory (including tests for language) AN, AVLT, CRT, CVMT, DS, EBMT,
FMT, IPALT, LDCT, LW, N-back test,
PMT, PWLT, RCFT, SRT, WLT, RBP,
RW, WLMT, WLRT, WMS, WRLRcT,
Language: AN, BNT, CFT, CVLT,
COWAT, IT, OR, RW, WFT, WD, ZBT
Executive function BD, FAB, DSST, GNG, LMN, MT, PM,
RPM, SILS, TMT, WAIS, WFT,
Attention and concentration: CST,
DS, LNS, PASAT, SDMT, Stroop,
TMTA&B
Visuo-spatial organization: CC, CoS,
CPT, FR, JLO, HT, PCBD, ScT,
SDMT, TMT(Part A), WAIS-R
Cognitive or psychomotor speed:
DSCT, WAIS-R, TMT(Part A), WFT
AN, animal naming; AVLT, Auditory verbal learning test; BD, block design; BNT, Boston
naming test; CFT, category verbal fluency test; COWAT, Controlled oral word; CPT,
constructional praxis test; CRT, constructional recall test.; CST, concept shifting test;
CVLT, California Verbal Learning Test; CVMT, continuous visual memory test; DS, digit
spans forward and backward of WAIS-R; DSCT, Digit symbol coding test (from WAIS);
DSST, Digit symbol substitution test; FMT, Milner facial memory test; EBMT, East Boston
Memory Test; FAB, Frontal assessment battery; FR, figure rotation from the Schaie-
Thurstone adult mental abilities test; GNG, Go-No-Go; HT, Hooper test; IPALT, Inglis
paired associates learning test; IT, Isaacs set test of verbal fluency; JLO, Judgment of
line orientation; LDCT, letter digit coding test; LMN, Luria m’s and n’s; LNS, Letter-
number sequencing; LW, list of words; 3MSE, Modified MMSE (100 scores); MEAMS,
Middlesex elderly assessment of mental state (12 scores); MMSE, Mini mental state
examination (30 scores); MMMSE, Modified Mini-Mental State Examination; MT, Matrix
test; OR, oral reading; PASAT, paced auditory serial addition task; PM, Porteusmaze; PMT,
Prose memory test; PCBD, Picture completion and block design; PWLT, picture word
learning test; RBP, Rivermead behavioral profile; RCFT, Rey-Osterrieth complex figure
test; RPM, raven progressive matrices test; RW, Rey’s words immediate and delayed
recall; ScT, scribble test; SDMT, symbol digit modalities test; SILS, Shipley Institute of
Living scale; SRT, selective reminding test (Buschke); TMTA&B, trail making test A and
B; WAIS, Wechsler adult intelligence scale; WAIS-R, Wechsler adult intelligence scale-
revised; WD, word discrimination; WFT, word fluency test; WLMT, word list memory test;
WLRT, Word list recall test; WRLRcT, Word list recognition test; WLT, word learning task;
WMS, Wechsler memory scale; ZBT, Zazzos barring test.
that were used for each of these cognitive domains are also
presented in Table 3.
Systematic Review
In total, 1,199 participants with subclinical hypothyroidism
were included in the systematic review. From the 15 studies
in our systematic review, 12 studies indicated a lack of
signiﬁcant association between subclinical hypothyroidism and
cognitive impairment in the elderly. These studies comprised
1,109 participants with subclinical hypothyroidism and therefore
contributed 92.5% of the population sampled to the outcome
of the systematic review. Of the remaining three studies, two
found an association, and one was inconclusive (Hogervorst
et al., 2008). The inconclusive study demonstrated an association
between log transformed TSH levels with decreasing MMSE
performance in hypothyroid participants, but it was not
speciﬁed whether the observed association was with overt
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hypothyroidism or with subclinical hypothyroidism. This study
was included in the systematic review but excluded from
meta-analysis.
A total of two studies found an association between subclinical
hypothyroidism and cognition in the elderly. The ﬁrst study
found (in 15 participants with subclinical hypothyroidism) that
high TSH levels were associated with worse verbal memory
and MMSE scores but not with speed of performance (Cook
et al., 2002). The second study found (in 42 participants
with subclinical hypothyroidism) that performances in MMSE
and Prose memory test were lower in participants with
subclinical hypothyroidism compared to euthyroid participants
(Resta et al., 2012). Performance in matrix test was also
slightly lower in subclinical hypothyroidism, but this was
not signiﬁcant. Summarily, from the studies that observed a
signiﬁcant association between subclinical hypothyroidism and
cognitive impairment, the cognitive domains aﬀected were global
cognition as assessed via MMSE; executive function as assessed
via matrix test; and memory as assessed via auditory verbal
learning test, prose memory test, and verbal ﬂuency. The two
studies combined comprised 57 participants with subclinical
hypothyroidism and contributed only 4.75% to the overall
population with subclinical hypothyroidism and to the outcome
of the systematic review.
Meta-analysis
To assess whether subclinical hypothyroidism was associated
with impairment of various cognitive domains, we analyzed
MMSE separately as a measure of global cognition. Ten out of the
15 studies provided MMSE results either at baseline or at follow-
up. The rest of the cognitive tests were categorized into tests of
executive function or of memory, as shown in Table 3. Data from
the 15 studies was pooled ﬁrst for cross-sectional analysis, and
meta-analyzed separately for global cognition (MMSE), executive
function, andmemory. The pooled ES forMMSEwas−0.01 (95%
CI −0.09, 0.08), with heterogeneity (I)2 of 55.1% (Figure 2A).
Pooled ES was <0.001 (95% CI −0.10, 0.09) for executive
function (I2 = 13.5%) (Figure 2B), and 0.01 (95%CI−0.12, 0.14)
for memory (I2 = 46.9%) (Figure 2C). These analyses indicated
that available evidence does not support an association of
subclinical hypothyroidism with worse performance in MMSE,
executive function or global cognition.
Prospective analysis was done for MMSE in four studies
from which prospective data was available (Figure 3). The
pooled ES was 0.03 (95% CI −0.001–0.07) P = 0.055, with
heterogeneity (I2) of<0.001%. Thus, subclinical hypothyroidism
was not signiﬁcantly associated with accelerated decline of global
cognition, as assessed by MMSE. Due to the small number of
available studies, prospective analysis was not done for executive
function or memory.
Subgroup and Sensitivity Analyses
Subgroup analyses were performed on studies with similar TSH
cut-oﬀ values, and in studies with similar study design (cross-
sectional or prospective). The ES of these diﬀerent subgroups
were essentially similar, indicating that in this meta-analysis,
FIGURE 2 | Forest plots depicting the cross-sectional associations
observed between subclinical hypothyroidism (compared to controls)
and cognitive performance in 10 studies, arranged according to the
weight of the studies. Data was pooled from cross-sectional studies and
baseline data of prospective studies. (A) Association between subclinical
hypothyroidism and global cognition as measured by MMSE, (B) Association
between subclinical hypothyroidism and executive function, and
(C) Association between subclinical hypothyroidism and memory. The pooled
effect sizes are displayed as diamonds. MMSE, Mini-mental state examination.
subclinical hypothyroidism was not signiﬁcantly associated with
cognitive impairment.
Discussion
On the basis of the ﬁndings of this systematic review
and meta-analysis we did not ﬁnd evidence supporting
an association of subclinical hypothyroidism with cognitive
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FIGURE 3 | Forest plots depicting the prospective analysis of
associations observed between subclinical hypothyroidism and
decline in global cognition as measured by MMSE, arranged
according to the weight of the studies. The pooled effect
sizes are displayed as diamonds. MMSE, Mini-mental state
examination.
impairment in relatively healthy, community-dwelling elderly.
Out of 15 observational studies, only two small cross-
sectional studies (Cook et al., 2002; Resta et al., 2012)
observed statistically signiﬁcant associations between subclinical
hypothyroidism and cognitive impairment, namely global
cognition (MMSE), and memory. All other studies indicated
a lack of association. No evidence was found that the
lack of association between subclinical hypothyroidism and
cognitive impairment was limited to unadjusted studies, or
to studies of lower methodological quality. Meta-analysis of
studies from which data for cross-sectional analysis could
be retrieved, revealed lack of association between subclinical
hypothyroidism and global cognition (assessed by MMSE) as
well as lack of association of subclinical hypothyroidism with
memory and executive function. Subgroup analyses by type
of study design showed a similar trend in the prospective
cohort studies group compared with the cross-sectional studies.
We also did not ﬁnd evidence supporting an association of
subclinical hypothyroidism with cognitive impairment in a
prospective analysis. However, the number of studies retrieved
for prospective analysis was low and the study quality (assessed
by scoring based on key indicators) varied.
Our results are in line with previous focused reviews
(Parle et al., 2010; Joﬀe et al., 2013) supporting a lack of
association between subclinical hypothyroidism and cognitive
impairment that largely drew upon the results from large
population based studies (Roberts et al., 2006). In contrast,
another review conducted on the association between TSH and
cognitive impairment in community dwelling and hospitalized
elderly (Annerbo and Lökk, 2013) reported some evidence
supporting the association between subclinical hypothyroidism
and cognitive impairment, which was driven by studies showing
an association between thyroid hormones and dementia.
Thus, previous observational studies on the association of
cognitive impairment and subclinical hypothyroidism have
yielded conﬂicting results. Our ﬁnding of lack of association
between subclinical hypothyroidism and cognitive impairment is
also in line with the results of two placebo controlled randomized
clinical trials (Jorde et al., 2006; Parle et al., 2010) that showed no
eﬀect of treatment with T4 on cognitive endpoints in participants
with subclinical hypothyroidism.
To our knowledge, this is the ﬁrst meta-analysis to
examine the cross-sectional and prospective associations between
subclinical hypothyroidism and cognitive impairment using
available evidence. By pooling the data from the 15 studies,
a total of 19,944 participants, of whom 1,199 had subclinical
hypothyroidism were analyzed. This increased the power to
detect potential associations and reduced the probability of
false-negative results (Resta et al., 2012). Case-control and
cross-sectional studies are more susceptible to bias, particularly
selection bias for case-control studies (Hulley et al., 2001).
Although bias cannot be excluded, almost all the cross-sectional
studies that fulﬁlled our quality criteria demonstrated the absence
of a statistically signiﬁcant association between subclinical
hypothyroidism and cognitive impairment (Hogervorst et al.,
2008; Park et al., 2010).
Overt hypothyroidism has been associated with global
cognitive impairment as well as with impairments in various
cognitive domains, notably in memory and executive function.
Because thyroid dysfunction can be seen as a continuum, it
has been hypothesized that subclinical hypothyroidism might
also be associated with mild cognitive impairment. The inverse
physiological relationship between circulatory levels of TSH and
thyroid hormones implies that in subclinical hypothyroidism,
thyroid hormone action may be slightly reduced (even though
circulatory thyroid hormones are still in the normal range),
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which might be associated with subtle defects in speciﬁc
cognitive domains, including memory and executive function.
Moreover, one might speculate that potential associations
between subclinical hypothyroidism and cognitive impairment
are stronger when TSH is markedly increased (TSH > 10
mIU/L) as compared to mild or moderate increases. Similarly,
it was found previously that associations between subclinical
hypothyroidism and risk for coronary heart disease andmortality
were strongest with a TSH concentration of 10 mIU/L or greater
(Rodondi et al., 2010).
This analysis has four main limitations. Firstly, all data were
obtained from observational studies, many of which are cross-
sectional studies. There is a possibility of bias in the selection
of included studies, bias and quality problems in the original
studies, publication bias, heterogeneity, and confounding (Stroup
et al., 2000). To limit bias in the selection of included studies,
broad inclusion criteria were used for studies that provided
quantitative data on the risk of cognitive impairment in elderly
participants with subclinical hypothyroidism. Furthermore,
sensitivity analyses were performed according to diﬀerences
between the studies and methodological study quality, as
recommended (Berlin, 1995; Stroup et al., 2000). Many of the
original studies did not have statistically signiﬁcant results, thus
a meta-analysis was conducted to increase the power to ﬁnd
an association. Still, the negative conclusion of this systematic
review and meta-analysis may be limited by inherent biases
and diﬀerences in study designs (Huston and Naylor, 1996).
However, the sensitivity analyses performed did not suggest that
the presented results meaningfully depended on diﬀerences in
study designs or other study characteristics.
Secondly, the possibility of misclassiﬁcation of subjects as
having subclinical hypothyroidism cannot be ruled out (Huston
and Naylor, 1996). In most of the studies, the diagnosis of
subclinical hypothyroidism was based on single assessment
of TSH, without repeated conﬁrmatory TSH measurement.
This could have resulted in inclusion of individuals with only
transiently elevated TSH levels. Furthermore, none of the
included studies used age-adjusted TSH reference ranges to
enroll the subjects. Since increased age has been associated
with an increase in the upper limit of the TSH reference range
(Zhu et al., 2006), the use of unadjusted reference ranges may
have resulted in misclassiﬁcation of some elderly participants
as having subclinical hypothyroidism. This misclassiﬁcation
may have resulted in underestimation of the association
between subclinical hypothyroidism and cognition. However,
since the 95% CI around the estimates are quite narrow and
the misclassiﬁcation is likely to be small, a large eﬀect of
subclinical hypothyroidism on cognition can be conﬁdently
ruled out.
Thirdly, the deﬁnitions of subclinical hypothyroidism and
cognitive decline were slightly diﬀerent between the studies.
The use of diﬀerent TSH cut-oﬀs reﬂects the absence of
consensus to deﬁne subclinical hypothyroidism (Helfand, 2004;
Surks et al., 2004). Some studies used a TSH upper limit
of <4.5 mIU/L (Cook et al., 2002; Park et al., 2010), and the
inclusion of those participants may have blunted the eﬀect of any
observed associations, since they may not have had subclinical
hypothyroidism (Surks et al., 2004). However, the sensitivity
analyses pooling more homogeneous studies gave similar
results indicating a lack of evidence supporting an association
of subclinical hypothyroidism with cognitive impairment.
However, onemight speculate that potential associations between
subclinical hypothyroidism and cognitive impairment might
only be present when TSH is markedly increased (TSH >
10mIU/L). Future studies using individual participant data
should be directed at analyzing available evidence for an
association between subclinical hypothyroidism and cognition
based on TSH categories, as was done previously for associations
between subclinical hypothyroidism and coronary heart disease
(Rodondi et al., 2010).
Fourthly, there were several diﬀerences in methodologies and
choice of cognitive domains that were tested in the studies
in this systematic review and meta-analysis. Thus, we cannot
exclude the possibility that subclinical hypothyroidism might be
associated with subtle defects in speciﬁc domains that can only
be identiﬁed using highly speciﬁc cognitive tests and measures.
Indeed, functional neuro-imaging studies in participants with
subclinical hypothyroidism and markedly elevated TSH levels
has revealed impairments in working memory and brain areas
associated with executive function that reversed by treatment
with T4 (Zhu et al., 2006). However, the clinical relevance
of such speciﬁc measures remains unclear. Moreover, diﬀerent
laboratory methods were used for the measurements of TSH and
fT4. In addition, TSH has a distinct circadian rhythm and time of
the measurements of TSH was not reported in the articles, which
may have aﬀected the results.
In conclusion, this systematic review and meta-analysis
provides no evidence that supports an association between
subclinical hypothyroidism and cognitive impairment in
relatively healthy, community dwelling elderly. However,
available prospective studies were limited. Thus, additional large,
high-quality studies are needed that will allow for more extended
analyses.
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